SCHEMBL22700418

SCHEMBL22700418

CC1=C(C2=C(C)C(=O)c3c(c(/C=N/c4cccc5ncccc45)c(O)c(O)c3C(C)C)C2=O)C(=O)c2cc(O)c(O)c(C(C)C)c2C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
KDM4E B2RXH2 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41
HSD17B10 Q99714 1/20 0.41
APAF1 O14727 1/20 0.39
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.32
ESR1 P03372 1/20 0.32
TP53 P04637 1/20 0.32
RAB9A P51151 1/20 0.32
PTK2B Q14289 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ERN1 O75460 2/20 0.31
BLM P54132 1/20 0.30
PIK3CD O00329 1/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22700398 0.81 MEN1 (0.35) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL22700765 0.80 SMN1; SMN2 (0.32) ALDH1A1KMT2ASMN1; SMN2
SCHEMBL22700400 0.80 MAPT (0.36) MAPTKDM4EMAPK1ALDH1A1MEN1
SCHEMBL22686504 0.74 ALB (0.42) MAPTKDM4EALOX15MAPK1CASP1
SCHEMBL22700775 0.74 MAOA (0.36) MAPTKDM4EALOX15HSD17B10ALDH1A1
SCHEMBL22700720 0.74 MAPT (0.42) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL22700661 0.73 AKR1B1 (0.50) MAPTKDM4EALOX15MAPK1CASP1
SCHEMBL22700390 0.73 MCL1 (0.50) MAPTKDM4EMAPK1ALDH1A1MEN1
SCHEMBL22700375 0.73 KDM4E (0.41) MAPTKDM4EMAPK1ALDH1A1MEN1
SCHEMBL22700489 0.72 BCL2 (0.40) HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF Nearmedic International Limited (CY) 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF DNM2, DNM1, MAVS MAPT 3116/4885KDM4E 2116/4885ALOX15 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.